216 related articles for article (PubMed ID: 22505561)
21. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
Sterzynska K; Kempisty B; Zawierucha P; Zabel M
Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
[TBL] [Abstract][Full Text] [Related]
22. A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.
Lin HC; Hsu HC; Hsieh CH; Wang HM; Huang CY; Wu MH; Tseng CP
Clin Chim Acta; 2013 Apr; 419():77-84. PubMed ID: 23415697
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
[TBL] [Abstract][Full Text] [Related]
24. Circulating epithelial cells in patients with thyroid carcinoma. Can they be identified in the blood?
Winkens T; Pachmann K; Freesmeyer M
Nuklearmedizin; 2013; 52(1):7-13. PubMed ID: 23254889
[TBL] [Abstract][Full Text] [Related]
25. Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial.
Xie J; Dong H; Chen H; Zhao R; Sinko PJ; Shen W; Wang J; Lu Y; Yang X; Xie F; Jia L
J Nanobiotechnology; 2015 Feb; 13():9. PubMed ID: 25643843
[TBL] [Abstract][Full Text] [Related]
26. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
[TBL] [Abstract][Full Text] [Related]
28. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
[TBL] [Abstract][Full Text] [Related]
29. Circulating epithelial cells in patients with benign colon diseases.
Pantel K; Denève E; Nocca D; Coffy A; Vendrell JP; Maudelonde T; Riethdorf S; Alix-Panabières C
Clin Chem; 2012 May; 58(5):936-40. PubMed ID: 22205690
[TBL] [Abstract][Full Text] [Related]
30. IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma.
Nel I; Baba HA; Weber F; Sitek B; Eisenacher M; Meyer HE; Schlaak JF; Hoffmann AC
Biomark Med; 2014; 8(5):687-98. PubMed ID: 25123037
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumor cells and EpCAM expression in neuroendocrine tumors.
Khan MS; Tsigani T; Rashid M; Rabouhans JS; Yu D; Luong TV; Caplin M; Meyer T
Clin Cancer Res; 2011 Jan; 17(2):337-45. PubMed ID: 21224371
[TBL] [Abstract][Full Text] [Related]
32. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
Rao CG; Chianese D; Doyle GV; Miller MC; Russell T; Sanders RA; Terstappen LW
Int J Oncol; 2005 Jul; 27(1):49-57. PubMed ID: 15942643
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
[TBL] [Abstract][Full Text] [Related]
34. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
35. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.
Rupp AK; Rupp C; Keller S; Brase JC; Ehehalt R; Fogel M; Moldenhauer G; Marmé F; Sültmann H; Altevogt P
Gynecol Oncol; 2011 Aug; 122(2):437-46. PubMed ID: 21601258
[TBL] [Abstract][Full Text] [Related]
36. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.
Gabriel MT; Calleja LR; Chalopin A; Ory B; Heymann D
Clin Chem; 2016 Apr; 62(4):571-81. PubMed ID: 26896446
[TBL] [Abstract][Full Text] [Related]
37. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.
de Wit S; van Dalum G; Lenferink AT; Tibbe AG; Hiltermann TJ; Groen HJ; van Rijn CJ; Terstappen LW
Sci Rep; 2015 Jul; 5():12270. PubMed ID: 26184843
[TBL] [Abstract][Full Text] [Related]
38. Determining tissue origin of circulating epithelial cells (CEC) in patients with differentiated thyroid cancer by real-time PCR using thyroid mRNA probes.
Sorg S; Pachmann K; Brede-Hekimian K; Freesmeyer M; Winkens T
Cancer Lett; 2015 Jan; 356(2 Pt B):491-5. PubMed ID: 25304372
[TBL] [Abstract][Full Text] [Related]
39. Revisiting the Roles of Pro-Metastatic EpCAM in Cancer.
Mohtar MA; Syafruddin SE; Nasir SN; Low TY
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32046162
[TBL] [Abstract][Full Text] [Related]
40. Circulating tumor cell enumeration by the CellSearch system: the clinician's guide to breast cancer treatment?
Beije N; Jager A; Sleijfer S
Cancer Treat Rev; 2015 Feb; 41(2):144-50. PubMed ID: 25542852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
